- Treatment of CMV retinitis (IV) in immunocompromised pts.
- Prophylaxis and prevention of CMV disease recurrence in pts with AIDS and solid organ transplant recipients (use for primary prophylaxis in HIV is FDA approved but not currently recommended; valganciclovir preferred).
- Herpes keratitis (ophthalmic gel)
- Castleman’s disease (limited data)
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2023 Unbound Medicine, Inc. All rights reserved